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variable. A univariate model estimating the effect of smoking on
health status was also run. RESULTS: After adjusting for demo-
graphics and other health status measures, smoking remained a
highly signiﬁcant factor affecting perceived health status,
although the inﬂuence of smoking decreased by 40%. In the uni-
variate model, the coefﬁcient on smoking was -0.43 (t = -15.23,
p < 0.001). When other explanatory variables were included in
the model, the coefﬁcient on smoking status was -0.26 (t =
-11.00, p < 0.001). In the ﬁnal model, all explanatory variables
showed a signiﬁcant effect on perceived health status, except for
sex. Factors with the highest effect on health status (largest
absolute t-statistics) were pain, any physical limitation, high
blood pressure, and smoking, respectively. CONCLUSIONS:
Although the outcome variable is measured on a ﬁve-point scale,
from 1 (“excellent”) to 5 (“poor”), performing an exploratory
generalized ordered logit model suggested similar associations.
The effect of smoking was consistent throughout the scale of
health status ratings.
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AAA is a prevalent health condition affecting up to 14% of males
and 6% of females. Untreated AAAs is a serious health concern
due to signiﬁcant risks of rupture and death. OBJECTIVES: Esti-
mate the cost-utility of elective EVAR compared to OSR for
treating non-ruptured AAAs. METHODS: A decision analytic
model was constructed to represent the long term cost-
effectiveness of AAA. A systematic review of the literature was
conducted for estimates of key model parameters (including tech-
nical and clinical success rates, complication rates, conversion
rates and mortality). The review of the literature was supple-
mented with a prospective follow-up of patients from a large ter-
tiary hospital for information on costs and health-related quality
of life. Cost-utility was assessed over a one-year period. Deter-
ministic sensitivity analyses were used to assess the impact of
methodological and modeling uncertainty and probabilistic sen-
sitivity analyses was used for parameter uncertainty. RESULTS:
The 59 comparative studies identiﬁed from the literature suggest
the technical and clinical success rates are lower for EVAR
patients, however, EVAR treated patients tended to be older,
male, and had larger aneurysms, increased surgical risk, and
more comorbidities than OSR trial patients. Our prospective
study showed success rates for both OSR and EVAR are very
high and complication rates are much lower than reported in the
published literature. Cost-utility based on success and complica-
tion rates from the literature suggests EVAR cost $160,176 per
QALY compared to OSR. However, results from our prospective
study suggest EVAR costs only $59,485 per QALY in all AAA
patients and may even dominate OSR in high surgical risk
patients. CONCLUSIONS: Using results from literature reviews
of non-randomized trials for input into an economic model can
be misleading. The predominance of non-randomized trials com-
paring EVAR and OSR highlights the importance of adjusting
for baseline imbalances in patient risk.
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OBJECTIVE: To examine the relationship between costs of
surgery in relation to changes in health status. METHODS: The
responses of 10,000 patients to a routine post-discharge survey
were evaluated (Health Outcomes Data Repository [HODaR]).
Respondents were asked to rate their health both prior to admis-
sion and on the day of survey completion (>40 days post-
discharge) on a scale of 1 (worst possible health) to 100 (best
possible health). Admissions were classiﬁed as either elective or
emergency procedures. The primary surgical procedure was clas-
siﬁed using 3-character OPCS4 codes. The cost for each admis-
sion was calculated using the NHS HRG grouping algorithm.
RESULTS: “Before” and “after” data were available for 6456
elective admissions and 1387 emergency admissions who had all
undergone a surgical procedure. Mean self-reported difference in
health status was 4.8 units (SD 20.7). There was no difference
in health change between elective or emergency admissions (p >
0.05). For elective procedures with 25 cases or more (n = 45 
procedures) a logarithmic relationship between cost and mean
health change was evident (DQoL = 6.3024 ¥ Lncost - 36.62; r2
= 0.57), and a linear function best described the same relation-
ship for emergency procedures (DQoL = 0.0022 ¥ cost + 1.4814;
r2 = 0.50). Procedures involving a notably improved cost effec-
tiveness ratio included tonsilectomy, cholecystectomy and
primary excision of lumbar inter-vertebral disc. The mean cost
effectiveness ratio for elective procedures was ≤250 per DQoL
unit and ≤440 per unit for emergency surgery. CONCLUSIONS:
At a macro level there was a distinct association between ﬁnan-
cial cost and short term outcome for operative procedures. The
mean cost effectiveness ratio for individual procedures showed
a linear association for emergency surgery and a logarithmic
association for elective surgery. Procedures which reduce pain
appear to be the most cost-effective where DQoL is the outcome.
